《7北京大学药学院执业药师习题串讲班《药物化学》练习题一.pdf》由会员分享，可在线阅读，更多相关《7北京大学药学院执业药师习题串讲班《药物化学》练习题一.pdf（18页珍藏版）》请在taowenge.com淘文阁网|工程机械CAD图纸|机械工程制图|CAD装配图下载|SolidWorks_CaTia_CAD_UG_PROE_设计图分享下载上搜索。
1、/18 2007 年北京大学药学院执业药师习题串讲班药物化学练习题一说明：1、本模拟题是仿照往年的试卷格式出的，给学生一种真题的感觉。2、按照考试安排，药化和药剂组成药学执业知识二），共140 题，其中药化占40，共 56 题。3、仿照考试卷的格式，药剂题在前，有84 题。药化题在后，药化的题从85 开始编号，故本模拟题从85题开始，与真实试卷相同。4、本模拟题对药化考试用书35 章的覆盖率是100。2007年国家执业药师资格考试模拟习题药学专业知识 二）药物化学部分一、最佳选择题共16题，每题 1分。每题的备选答案中只有一个最佳答案。85下列药物中哪种是-内酰胺酶抑制剂A阿莫西林B阿 M 卡
2、星C克拉维酸D头孢羟氨苄E多西环素86如下化学结构的药物名称是NNNNH3CClA三唑仑 B艾司唑仑C阿普唑仑D劳拉西泮E氟西泮87祛痰药溴己新分子中环己烷羟基化、N-去甲基的活性代谢物是A羧甲司坦B苯丙哌林C右美沙芬D氨溴索E己酰半胱氨酸/18 88具下列化学结构的是何种药物NHOHOClSNH2OOA呋塞 MB依他尼酸C氯噻酮D氢氯噻嗪E乙酰唑胺89奋乃静在空气中或日光下放置渐变红色，分子中不稳定的结构部分为A羟基 B哌嗪环C侧链部分D苯环 E吩噻嗪环90哪个是 1R,2S）麻黄碱ABCHOHHNHCH3CH3OHHCH3HNHCH3HOHHNHCH3CH3DEOHCH3HNHCH3HHO
3、HHCH3CH391在制备注射液时，需要加抗氧剂并冲氮气的是A苯巴比妥钠B吗啡 C对乙酰氨基酚D盐酸美沙酮E盐酸曲马多92维生素B1I）极性大、口服吸收差，对其进行结构修饰制成丙舒硫胺抗坏血酸B L(异抗坏血酸CD(抗坏血酸DD(异抗坏血酸E消旋体95下列化学结构的药物是NH3CH3CCH3OONCH3CH3+Br-A溴丙胺太林B甲溴东莨菪碱C丁溴东莨菪碱D溴新斯的明E溴甲阿托品96哪个药物化学名为2,6-二甲基-4-(3-硝基苯基-1,4-二氢-3,5 吡啶二甲酸甲乙酯A尼群地平B氨氯地平C尼莫地平D地尔硫卓E硝苯地平97哪个药物有两个手性中心A吡喹酮 B磷酸氯喹C左旋咪唑D磷酸伯氨喹E乙胺
4、嘧啶98下列哪个药物的立体异构体作用强度相同A氯苯那敏B乙胺丁醇C萘普生D氧氟沙星E磷酸氯喹99下列反应中哪个不是相代谢反应A与谷胱甘肽结合B与蛋白质结合C与葡萄糖醛酸结合D甲基化反应E与氨基酸结合100以下哪个说法不正确AM 力农的吡啶环上增加了甲基和氰基B盐酸普罗帕酮的两个异构体在药物代谢动力学上没有差别C硝酸酯类的抗心绞痛药物机制是释放NO 血管舒张因子D盐酸美西律在使用中需要经常测定尿的pH 值，防止血药浓度过高E氨力农是磷酸二酯酶抑制剂二、配伍选择题共32 题，每题 0.5 分。备选答案在前，试卷在后。每组看干题。每组题均对应同一组备选答案，每题只有一个正确答案。每个备选文档编码:C
5、T8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM
6、6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3
7、D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码
8、:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6
9、HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 Z
10、P3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档
11、编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3/18 答案可重复选用，也可不选用。101103 NSHCOOHCH3CH3OHNOHHHNHONNOOCH3 H2ONSHCOOHCH3CH3OHNOHHH2NH 3H2OH3CONSHCH3CH3HOHOOHNOCOOHS DNSClCOOHOHNOHHNH2 H2ONS
12、CH3COOHOHNOHHNH2HO H2O101头孢克洛102氨苄西林103哌拉西林104107 A枸橼酸他莫昔芬B巯嘌呤C紫衫醇D吉非替尼E异环磷酰胺104作用机制是抗代谢105作用机制是有丝分裂抑制剂106作用机制是竞争雌激素受体107作用机制是表皮生长因子受体酪氨酸激酶抑制剂108111 A吗啡B哌替啶C美沙酮D纳洛酮E芬太尼文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V
13、2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5
14、I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10
15、E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT
16、8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6
17、V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D
18、10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:
19、CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3/18 108为合成镇痛药，化学结构属哌啶类，镇痛作用弱于吗啡，有成瘾性109为合成镇痛药，化学结构属哌啶类，镇痛作用强于吗啡，作用时间短暂，临床用于辅助麻醉110为天然生物碱，镇痛作用强，成瘾性大，临床用作镇痛药，属麻醉性药物，须按国家法令管理111为阿片受体拮抗剂，临床用于吗啡等引起的呼吸抑制的解救112115 A奥卡西平B苯妥英钠C奥司他韦D加替沙星E乙胺丁醇112具有饱和代谢动力学特点113化学结构中含有2 个手性碳原子，却有三个对映异构体114其 8 位有甲氧基的喹诺酮抗菌药115是酯型前药，经酯酶代谢产生活性1
20、16119 A甲睾酮B雌二醇C黄体酮D醋酸地塞M 松E苯丙酸诺龙116临床用于雌激素缺乏引起的病症117作为蛋白同化激素用于临床118主要用于肾上腺皮质功能减退症等119为雄激素，可口服，用于男性缺乏睾丸素引起的疾病120123 A4-(2-异丙氨基-1-羟基 乙基-l，2-苯二酚盐酸盐B(1R,2S-2-甲氨基-苯丙烷-1-醇盐酸盐C1-异丙氨基-3-(1-萘氧基-2-丙醇盐酸盐D(R-4-2-(甲氨基-1-羟基乙基-1，2-苯二酚E2-(2，6-二氯苯基 亚氨基 咪唑烷盐酸盐120盐酸麻黄碱121盐酸普萘洛尔122盐酸异丙肾上腺素123盐酸可乐定124125 A格列本脲B甲苯磺丁脲C莫沙必
21、利D西沙必利E阿卡波糖124化学名为4-甲基-N-(丁氨基 羰基 苯磺酰胺125有同质多晶现象126128 A结构特异性药物B结构非特异性药物C lgPD药效构象EpH 126评价药物亲脂性文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3
22、文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A
23、5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7
24、N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1
25、U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F
26、9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8
27、N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3/18 127药效主要受药物理化性质的影响128药物与受体相互作用时，与受
28、体互补的药物构象129132 A炔雌醇 B M 非司酮 C黄体酮D醋酸曲安萘德E非那雄胺129 11位是 4-二甲氨基苯基130 5-还原酶抑制剂131 9位有 F取代，可治疗皮肤病132其乙醇溶液加硝酸银发生白色沉淀三、多选题共8 题，每题 1 分。每题的备选答案中有2 个或 2 个以上正确答案。少选或多选均不得分。133下列哪些与氯贝丁酯相符A提供了一个发展苯氧乙酸类降脂药的先导化合物，推动了该类药物的发展B用于治疗高脂血症C副作用是谷丙转氨酶暂时上升D分子中有手性碳E具有抗心律失常作用134结构式如下的药物SH2NOONNH3CCF3A是 CYP2D6 酶的抑制剂，与氟康唑、氟代他汀合用
29、，可使本品血药浓度升高B用于治疗风湿性关节炎疼痛C吸收不好，生物利用度低D可诱导心脏病发作，被FDA 要求在说明书上写出相关风险提示E是非酸性的前药135某孕妇，曾有肝功能不正常历史，突发哮喘，可选择下列哪些药物A福莫特罗B丙酸氟替卡松C布地奈德D盐酸班布特罗E沙丁胺醇136属于中兴奋类治疗老年性痴呆的药物有A茴拉西坦B石衫碱甲C吡拉西坦文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT
30、8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6
31、V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D
32、10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:
33、CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 H
34、M6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP
35、3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编
36、码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3/18 D利斯的明E盐酸多奈哌齐137下列药物中哪些含咪唑结构A呋喃妥因B硝酸咪康唑C阿昔洛韦D氟康唑 E酮康唑138抗溃疡药雷尼替丁具有下列哪些性质AH2受体拮抗剂B结构中含有呋喃环C用于抗过敏性疾病D为反式体，顺式体无活性E本品为无活性的前药，经H+催化重排为活性物质139以下哪些药物是前药A塞替哌 B卡莫氟C异环磷酰胺D甲磺酸伊马替尼E卡莫司汀140盐酸小檗碱的性质与下列哪些相符A在碱性条件下可被高锰酸钾氧化B具有抗病毒作用C小檗碱以三种异构体形式存在，季铵碱式最稳定D主要用于菌痢、肠炎E黄色结晶性粉末，味极苦练
37、习题一 答案一、最佳选择题85C86C87D88C89 E90 C91 B92D 93C94A95D96A97 A98E99B100B 二、配伍选择题101D102B103A104B105C106A 107D108 B 109E110A111D112 B113E114D115C116B 117E118D119A120 B121C122A123 E124B 125D126C127B128D129B130E131D132A 三、多选题133ABCD134 ABD135 ABC136 AC137 ABCE 138ABD139 ABC140 ACDE 2007年执业药师药物化学练习题二本套题不按题型编
38、号，是讲课的例题，各题的题型标在该题后为了简单起见，最佳选择题简写为最佳），配伍选择题简写为配伍），多选题题简写为多选）。文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D1
39、0E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:C
40、T8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM
41、6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3
42、D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码
43、:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6
44、HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3/18 1、巯基嘌呤属于哪类抗肿瘤药物最佳）A抗代谢物B金属配合物C烷化剂D抗有丝分裂E酶抑制剂2、下列哪个是替莫西林最佳）AOHNNH HO
45、SHCOONaBNSHCOOHCH3CH3OHNOHHH2NH3H2OCNSCH3CH3HHONOCOOHHHOHNNNCH3OOODNSCH3CH3HHONOHOHONH2HHOENSOCH3COOHCH3CH3OHNOHHOOS3、下列药物中哪个不属于孕甾烷类最佳）AM 非司酮B醋酸甲地孕酮C甲睾酮D黄体酮E醋酸甲羟孕酮47 配伍）A盐酸西替利嗪B马来酸氯苯那敏C盐酸赛庚啶D特非那定E盐酸苯海拉明4氨基醚类H1受体拮抗剂5哌嗪类H1受体拮抗剂6丙胺类H1受体拮抗剂7三环类H1受体拮抗剂8下列哪些是胆碱酯酶抑制剂类的老年痴呆治疗药物多选）A盐酸多奈哌齐B吡拉西坦C利斯的明D石杉碱甲E氢溴酸加
46、兰他敏9属于磷酸二酯酶抑制剂类的平喘药最佳）A异丙托溴铵B孟鲁司特C茶碱D沙美特罗E.丙酸倍氯M 松文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码
47、:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6
48、HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 Z
49、P3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档
50、编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X6 HM6V5I8N7N1 ZP3D10E2W1U3文档编码:CT8V2F9A5X